Hydrogen sulphide "a double-faced Janus" in amyotrophic lateral sclerosis (ALS)

We have recently published a paper in Annals of Neurology entitled “Evidence of Hydrogen Sulphide involvement in Amyotrophic Lateral Sclerosis” [1] where we reported a study performed in patients, and in a genetic model of familial ALS. The outcome of this study is an original finding: the overproduction of hydrogen sulphide (H 2 S) in the human patients and in the animal model. We also show that H 2 S is produced, mainly, by glial cells, is toxic to motor neurons and increases significantly cytosolic Ca 2+ concentration. Altogether, our data introduce H 2 S as a new contestant in the ALS-related toxic pathways, which has potential implications for innovative drug design in ALS.

[1]  P. Calabresi,et al.  Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis , 2015, Annals of neurology.

[2]  S. Ajroud‐Driss,et al.  Sporadic and hereditary amyotrophic lateral sclerosis (ALS). , 2015, Biochimica et biophysica acta.

[3]  M. Swash,et al.  The expanding syndrome of amyotrophic lateral sclerosis: a clinical and molecular odyssey , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  A. Lombès,et al.  Oxidation of hydrogen sulfide by human liver mitochondria. , 2014, Nitric oxide : biology and chemistry.

[5]  R. Tapia,et al.  Spinal inhibitory circuits and their role in motor neuron degeneration , 2014, Neuropharmacology.

[6]  E. Gascon,et al.  The Emerging Roles of MicroRNAs in the Pathogenesis of Frontotemporal Dementia–Amyotrophic Lateral Sclerosis (FTD-ALS) Spectrum Disorders , 2014, Journal of neurogenetics.

[7]  K. Yanagi,et al.  Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part I. Biochemical and physiological mechanisms , 2014, British journal of pharmacology.

[8]  H. Kimura.  Production and physiological effects of hydrogen sulfide. , 2014, Antioxidants & redox signaling.

[9]  Adriano Chiò,et al.  State of play in amyotrophic lateral sclerosis genetics , 2013, Nature Neuroscience.

[10]  H. Kimura.  Physiological role of hydrogen sulfide and polysulfide in the central nervous system , 2013, Neurochemistry International.

[11]  M. Galantucci,et al.  Hydrogen sulfide slows down progression of experimental Alzheimer’s disease by targeting multiple pathophysiological mechanisms , 2013, Neurobiology of Learning and Memory.

[12]  Lingyun Wu,et al.  Oxygen-sensitive mitochondrial accumulation of cystathionine β-synthase mediated by Lon protease , 2013, Proceedings of the National Academy of Sciences.

[13]  M. Swash,et al.  Controversies and priorities in amyotrophic lateral sclerosis , 2013, The Lancet Neurology.

[14]  Jianhua Li,et al.  Hydrogen sulfide attenuates spatial memory impairment and hippocampal neuroinflammation in beta-amyloid rat model of Alzheimer’s disease , 2012, Journal of Neuroinflammation.

[15]  A. Akaike,et al.  Involvement of ERK in NMDA receptor-independent cortical neurotoxicity of hydrogen sulfide. , 2011, Biochemical and biophysical research communications.

[16]  Honglian Shi,et al.  Hypoxia inducible factor-1 as a target for neurodegenerative diseases. , 2011, Current medicinal chemistry.

[17]  M. Kaneki,et al.  Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease. , 2011, Antioxidants & redox signaling.

[18]  J. Lasiene,et al.  Glial Cells in Amyotrophic Lateral Sclerosis , 2011, Neurology research international.

[19]  Nam Sang Cheung,et al.  Gene profiling reveals hydrogen sulphide recruits death signaling via the N‐methyl‐D‐aspartate receptor identifying commonalities with excitotoxicity , 2011, Journal of cellular physiology.

[20]  J. Bian,et al.  Protective effect of hydrogen sulphide against 6‐OHDA‐induced cell injury in SH‐SY5Y cells involves PKC/PI3K/Akt pathway , 2010, British journal of pharmacology.

[21]  J. Bian,et al.  Neuroprotective effects of hydrogen sulfide on Parkinson’s disease rat models , 2010, Aging cell.

[22]  S. Snyder,et al.  Signaling by Gasotransmitters , 2009, Science Signaling.

[23]  Xun Hu,et al.  Mutations in FUS, an RNA Processing Protein, Cause Familial Amyotrophic Lateral Sclerosis Type 6 , 2009, Science.

[24]  J. Haines,et al.  Mutations in the FUS/TLS Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2009, Science.

[25]  P. Leigh,et al.  Amyotrophic lateral sclerosis , 2009, Orphanet journal of rare diseases.

[26]  P. Wong,et al.  Hydrogen Sulfide Inhibits Rotenone-Induced Apoptosis via Preservation of Mitochondrial Function , 2009, Molecular Pharmacology.

[27]  J. Bian,et al.  Hydrogen sulfide protects astrocytes against H(2)O(2)-induced neural injury via enhancing glutamate uptake. , 2008, Free radical biology & medicine.

[28]  P. Moore,et al.  Hydrogen sulfide induced neuronal death occurs via glutamate receptor and is associated with calpain activation and lysosomal rupture in mouse primary cortical neurons , 2007, Neuropharmacology.

[29]  H. Akiyama,et al.  TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. , 2006, Biochemical and biophysical research communications.

[30]  Jean-Pierre Julien,et al.  Transgenic mouse models of amyotrophic lateral sclerosis. , 2006, Biochimica et biophysica acta.

[31]  K. Hensley,et al.  On the relation of oxidative stress to neuroinflammation: lessons learned from the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. , 2006, Antioxidants & redox signaling.

[32]  Bruce L. Miller,et al.  Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.

[33]  D. Borchelt,et al.  Mechanisms of selective motor neuron death in transgenic mouse models of motor neuron disease , 1996, Neurology.

[34]  A. Slivka,et al.  Histochemical evaluation of glutathione in brain , 1987, Brain Research.

[35]  A. Samhan-Arias,et al.  Hydrogen sulfide raises cytosolic calcium in neurons through activation of L-type Ca2+ channels. , 2008, Antioxidants & redox signaling.